SCHEMBL8205974

SCHEMBL8205974

CCCC(C(=O)NCC(=O)CF)c1cccn(Cc2ccccc2)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.47
KDM4E B2RXH2 10/20 0.44
ALDH1A1 P00352 8/20 0.44
POLB P06746 3/20 0.44
LMNA P02545 2/20 0.44
BRD2 P25440 1/20 0.44
BRD3 Q15059 1/20 0.44
BRDT Q58F21 1/20 0.44
SMN1; SMN2 Q16637 4/20 0.43
HPGD P15428 3/20 0.43
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
MAPT P10636 4/20 0.42
RECQL P46063 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3175794 0.80 CASP3 (0.46) BRD4KDM4EALDH1A1POLBLMNA
SCHEMBL3177116 0.79 BRD4 (0.51) BRD4KDM4EALDH1A1POLBLMNA
SCHEMBL3183997 0.75 KDM4E (0.38) BRD4KDM4EALDH1A1POLBLMNA
SCHEMBL13531564 0.73 BRD4 (0.45) BRD4KDM4EALDH1A1POLBLMNA
SCHEMBL3175796 0.72 BRD4 (0.53) BRD4KDM4EALDH1A1POLBLMNA
SCHEMBL3166284 0.71 CASP3 (0.47) BRD4KDM4EALDH1A1POLBLMNA
SCHEMBL8208981 0.68 BRD4 (0.43) BRD4KDM4EALDH1A1POLBLMNA
SCHEMBL8208989 0.68 BRD4 (0.42) BRD4KDM4EALDH1A1POLBLMNA
SCHEMBL3182350 0.67 KDM4E (0.39) BRD4KDM4EALDH1A1POLBLMNA
SCHEMBL3172374 0.67 CASP3 (0.49) BRD4KDM4EALDH1A1POLBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008056898-A1 CASPASE INHIBITORS BASED ON PYRIDAZINONE SCAFFOLD LG LIFE SCIENCES LTD. (KR) 2008-05-15 WO disclosed